Follow InterQual and PA DHS bulletins for prior authorization

Refer to InterQual criteria and the Pennsylvania Department of Human Services (PA DHS) Medical Assistance bulletins when submitting prior authorization (PA) requests for specific items (e.g., hospital‑grade breast pumps, lower extremity orthoses, orthopedic shoes/boots, tracheostomy speaking valves/voice prosthetic devices) and to determine device‑specific clinical thresholds and PA requirements.

• Use InterQual Client Defined CPs for home mechanical ventilation and noninvasive airway assistive devices for clinical coverage thresholds.
• Follow the cited PA DHS Medical Assistance Bulletins for PA processes and item‑specific criteria (see policy references and the Policy History addition).

Obtain PA and physician documentation for replacements and upgrades

Replacement requests for DME beyond the Reasonable Useful Lifetime (RUL) and requests to upgrade equipment require prior authorization and supporting documentation. Upgrades are treated as a new service and need physician documentation demonstrating a change in the member’s clinical condition.

• Default RUL is 5 years unless otherwise stated in policy or contract.
• Upgrades require the same documentation as a new provision (physician documentation of change in condition).

Document PaCO2 and targeted ventilatory goals in PA requests

Include arterial PaCO2 measurement and the intended ventilatory goals in PA documentation for long‑term NIPPV/BPAP in COPD; evidence‑based trials targeted baseline hypercapnia and specified goals (e.g., reduction in PaCO2).

• Document baseline awake PaCO2 and the clinical goal (examples in trials: target ≥20% reduction or reduction to <6.5 kPa).
• Reference InterQual and trial criteria when arguing medical necessity for home ventilators in hypercapnic COPD.

Consult PA DHS Medical Assistance Bulletins for PA details

Consult the Pennsylvania Department of Human Services Medical Assistance Bulletins cited in this policy for item‑specific prior authorization guidance (hospital grade breast pumps, lower extremity orthoses, orthopedic shoes/boots, tracheostomy speaking valves/voice prosthetic devices). Failure to follow those bulletin requirements may necessitate PA or risk denial.

• Bulletins contain the PA submission rules and clinical criteria for each listed item.
• Policy History explicitly added instruction to refer to these PA DHS bulletins for coverage criteria.

Follow InterQual sequencing and physiologic thresholds for respiratory devices

Sequence respiratory devices per InterQual and guideline thresholds: HMVs and bi‑level PAP must meet InterQual criteria and physiologic thresholds (e.g., PaCO2) and should not be supplied solely to deliver PAP modes that are explicitly NMN.

• HMVs (E0465/E0466) are medically necessary only per InterQual for neuromuscular, restrictive thoracic disease, or select chronic respiratory failure scenarios.
• Do not authorize HMVs when used only in bi‑level PAP mode (E0470/E0471) or only to deliver continuous/intermittent PAP (E0465/E0466) — those uses are not medically necessary per policy.

(No additional action specified)

(See related documentation callouts for required records and data.)

Use CPAP/APAP first—reserve NIV if CPAP ineffective

For obesity hypoventilation syndrome, initiate CPAP/APAP as first‑line per guideline evidence; reserve NIV/BPAP when CPAP is ineffective and document rationale for escalation.

• Masa et al. found CPAP may be preferred first‑line with NIV used if CPAP fails—document trial of CPAP and clinical response before NIV.
• AASM recommends initiating PAP with APAP at home or in‑lab and using CPAP/APAP over BPAP for routine OSA regimes.

Document PAP initiation method and escalation per AASM guidance

Initiate PAP per AASM recommendations (APAP at home or in‑lab titration) and prefer CPAP/APAP over BPAP for routine OSA; include documentation of initiation method and troubleshooting/support interventions in the medical record.

• Document whether PAP initiation was APAP at home or in‑lab titration and record educational/behavioral interventions provided.
• If escalating to BPAP, document why CPAP/APAP was inadequate.
• Refer to AASM recommendations for expected initiation/escalation steps.

Keep complete medical records documenting necessity

Maintain complete, legible medical records to support medical necessity: history, physical exam, and pertinent diagnostic test results must be available upon request to substantiate PA and coverage decisions.

• Records should include relevant histories, exams, and diagnostic test results that directly support the requested DME.
• Make records available upon request for medical review.

Submit physician documentation for upgrades and standard docs for replacements

Provide physician documentation demonstrating change in clinical condition for upgrades and include the same documentation required for an initial provision; document routine wear for replacements and pediatric growth allowances when applicable.

• Upgrades: treat request as a new service with full supporting documentation from the physician.
• Replacements: document RUL exceedance (default 5 years) and irreparability; document routine wear if applicable.
• Pediatric DME must show minimum growth allowance (2 in seat width, 3 in seat depth).

Include ventilator/downloaded device data to demonstrate adherence

Provide objective device‑recorded downloads (built‑in ventilator software or smartcard) showing usage hours and ventilation parameters (e.g., leaks, pressures, tidal volume, backup frequency) to document adherence and effectiveness for NIV/BPAP/HMV.

• Include average nightly hours and percent of nights meeting adherence thresholds.
• Device logs may show inspiratory/expiratory PAP, tidal volume, minute ventilation, respiratory rate, and percent triggered breaths.

Document persistent hypercapnia and plan for home NIV after COPD exacerbation

When requesting home NIV after a COPD exacerbation, document persistent hypercapnia (PaCO2) following the acute event, describe the clinical course, and include the plan comparing home NIV plus oxygen versus oxygen alone with prescribed nightly hours.

• Include description of the prior acute exacerbation, timing of measurements, and oxygen prescription (e.g., oxygen duration/flow) used in the supporting trial protocols.
• Document the intended nightly ventilator usage (trials often instructed ≥6 hours/night).

Document PaCO2 timing and follow‑up expectations for NIV in COPD

For NIPPV/NIV in COPD, document the timing of PaCO2 measurements relative to hospitalization or exacerbation (e.g., persistent hypercapnia at least 2 weeks after hospital discharge) and plan for follow‑up evaluation within about 6 months showing improvement, stabilization, or target PaCO2 reduction.

• Provide arterial blood gas PaCO2 values with dates and indicate whether hypercapnia persisted ≥2 weeks post‑exacerbation.
• Document follow‑up plans and intended metrics for success (normalization, stabilization, ≥20% reduction in PaCO2, or symptom improvement within 6 months).

Risk of denial if item excluded or not ordered by authorized clinician

Items excluded from coverage or not ordered by an authorized clinician (physician or NP/CNS/PA acting within scope) risk denial. Ensure orders are from authorized providers and that the item is not listed as excluded.

• Verify ordering clinician is a physician or an authorized NP/CNS/PA acting within scope per state law.
• Confirm the device is not a fully implanted device or otherwise excluded under the policy before submitting PA.

Implanted devices are not covered as DME

Do not bill implanted devices as DME. Any device fully implanted into the body is not covered under the DME benefit; implanted components are considered under the medical‑surgical benefit and would be denied under DME.

• External components (e.g., cochlear external components) may be DME, but implantable components are medical‑surgical—confirm benefit type before submission.

Awake PaCO2 <52 mm Hg may make BPAP/NIV requests unproven

Requests for BPAP/NIV in COPD where the awake arterial PaCO2 is less than 52 mm Hg on room air are considered unproven and may be denied; include awake PaCO2 to demonstrate eligibility per physiologic thresholds.

• Policy states HMVs and BPAP are unproven for stable COPD when awake PaCO2 < 52 mm Hg.
• Even if asleep PaCO2 meets other thresholds, an awake PaCO2 <52 mm Hg undermines evidence for benefit per policy language.

Insufficient documented adherence (<4 hrs/night over 21–30 days) risks denial

Document objective adherence data; BPAP/NIV for CSA/OSA is considered unproven when device use is less than 4 hours per night on at least 21–30 consecutive days—insufficient adherence may risk denial.

• Adherence thresholds referenced include ≥4 hours/night or ≥4 hours/night on 70% of nights over a consecutive 30‑day period for continued coverage.
• Provide device downloads showing nightly hours and percent of nights meeting the threshold.

Follow PA DHS bulletin PA rules or risk denial for bulletin items

Failure to follow the Pennsylvania DHS Medical Assistance Bulletin prior authorization guidelines for the listed items (hospital grade breast pumps, lower extremity orthoses, orthopedic shoes/boots, tracheostomy speaking valves/voice prosthetic devices) may result in denial or the need to obtain PA per state bulletin instructions.

• Policy History added instruction to consult specific PA DHS bulletins for these items; include bulletin‑required documentation when submitting PA.
• Check the referenced bulletin URLs in the policy References section for the exact PA submission requirements.

Maintain and provide complete medical records for reviews

Maintain and make available medical records that fully support the medical necessity for requested services, including history, physical exam, and pertinent diagnostic results; documentation must be legible and provided upon request during reviews.

• Records should include history, exam, and diagnostic test/procedure results
• Documentation must be legible and available on request

Provide physician documentation to justify upgrades; treated as new requests

Upgrades require physician documentation demonstrating a change in the member's medical condition and must be supported by the same documentation required for an initial provision of equipment (treated as a new request).

• Submit full initial-request documentation for upgrade requests
• Explain clinical change necessitating the upgrade in physician notes

Submit device-recorded usage and parameter downloads to support coverage

Provide device-recorded usage and downloaded ventilator parameters (usage hours, pressures, leaks, tidal volume, minute ventilation, backup rates, percent triggered breaths) to document adherence and effectiveness when requesting coverage or continued use.

• Include average nightly hours and percent nights meeting adherence thresholds when available
• Submit built-in software reports or smartcard downloads

Include recent blood gas results and prior acute event description with NIV requests

Include recent arterial blood gas results (PaCO2 and PaO2), a description of the prior acute COPD exacerbation, and the current oxygen prescription when requesting home NIV for persistent hypercapnia after an exacerbation.

• Provide PaCO2 and PaO2 values and dates
• Describe prior acute event and specify oxygen regimen and prescribed nightly NIV hours

Document PaCO2 values and clinical follow-up showing persistence or improvement

Provide arterial blood gas PaCO2 values with dates and clinical follow-up documentation demonstrating timing relative to exacerbation (e.g., persistent hypercapnia ≥2 weeks post-hospitalization) and evidence of improvement, stabilization, or targeted reduction in PaCO2 within follow-up assessments.

• Show PaCO2 measurement dates and values and follow-up evaluations within ~6 months
• Document evidence of PaCO2 improvement, stabilization, or ≥20% reduction from baseline

Include PAP titration records and adherence/support interventions

Provide PAP titration records, prior PAP trials, and documentation of adherence-support interventions (education, mask fitting, humidification, troubleshooting, behavioral or supportive interventions) to demonstrate attempts to optimize therapy before escalating to alternative modalities.

• Include prior titration settings and trial durations
• Document educational/troubleshooting interventions and behavioral/supportive efforts